Concepedia

Eduardo Diniz Callegari

ED

Statistics

Publications

4

Citations

673

H-Index

4

Active since

2021

Affiliations

Pontifícia Universidade Católica de Minas Gerais(Current)

Universidade Federal de Ouro Preto

McMaster University

Impact

Monash University

Eduardo Diniz Callegari is an author at Pontifícia Universidade Católica de Minas Gerais specializing in pharmacotherapy, pharmacy, and infectious disease pharmacotherapy.

Publications per year

2021–2023

4

Publications

4

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial

Gilmar Reis, Eduardo Augusto dos Santos Moreira-Silva, Daniela Carla Medeiros Silva et al. · The Lancet Global Health · 2021 · 400 citations · Full text

, , +10

Early Treatment with Pegylated Interferon Lambda for Covid-19

Gilmar Reis, Eduardo A.S. Moreira Silva, Daniela C. Medeiros Silva et al. · New England Journal of Medicine · 2023 · 174 citations · Full text

, , +12

RETRACTED: Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial

Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva et al. · The Lancet Regional Health - Americas · 2021 · 63 citations · Full text

, , +13

Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19

Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva et al. · Annals of Internal Medicine · 2023 · 36 citations · Full text

, , +17

1–4 of 4